- Home
- RARE vs ARLP Comparison
RARE vs ARLP Comparison
Compare RARE & ARLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RARE | ARLP |
|---|---|---|
| Founded | 2010 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.3B |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | RARE | ARLP |
|---|---|---|
| Price | $36.37 | $24.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $85.20 | $29.50 |
| AVG Volume (30 Days) | ★ 1.3M | 271.1K |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 9.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.89 |
| Revenue | $630,598,000.00 | ★ $2,249,390,000.00 |
| Revenue This Year | $19.09 | N/A |
| Revenue Next Year | $20.62 | $3.41 |
| P/E Ratio | ★ N/A | $12.81 |
| Revenue Growth | ★ 20.63 | N/A |
| 52 Week Low | $25.81 | $22.20 |
| 52 Week High | $50.00 | $30.56 |
Technical Indicators
Market Signals| Indicator | RARE | ARLP |
|---|---|---|
| Relative Strength Index (RSI) | 62.08 | 51.91 |
| Support Level | $33.16 | $23.50 |
| Resistance Level | $34.77 | $24.60 |
| Average True Range (ATR) | 1.52 | 0.60 |
| MACD | 0.36 | 0.01 |
| Stochastic Oscillator | 83.52 | 55.22 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About ARLP Alliance Resource Partners L.P. Common Units representing Limited Partners Interests
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments: Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.